Delivery Order SPE2DB20D1100-SPE2DB24FA8S7

Award Date 3/21/24
Potential Completion Date 3/22/24
Potential Value $7.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $1,097.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a completion date of March 5, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) worth up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,021.25 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is issued under an existing indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,467.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical and medical supply products to support military treatment programs and facilities under various...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $17,156.46 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,291.24 contract is for the supply of WEGOVY 2.4 mg/0.75 mL pens to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D2007|SPE2DB24FJ1MD) worth $1,257.04 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a potential value of $3,291.24 and a completion date of January 29, 2024. AmerisourceBergen Drug Corp serves as the prime contractor, providing these specialty medications to support military treatment programs and facilities. This delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $1,097.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. This order is part of an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp as the sole prime contractor to deliver a comprehensive range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $4,388.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. This award is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $2,194.16 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. This award is part of an indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued up to $999,999,999.00, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA8S7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is valued at $7,085.94 and has a period of performance through March 22, 2024. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Generated 6/20/24, 9:34 AM